SCHEMBL5730454

SCHEMBL5730454

CCOc1nc(N2CCCNCC2)nc2c1sc1nc(-c3ccccc3)cc(C)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCI P41743 5/20 0.46
▸ HTR2C P28335 1/20 0.42
▸ MAPT P10636 2/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ KHK P50053 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ PRKCZ Q05513 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2614860 0.97 HTR2C (0.44) PRKCIHTR2CMAPTMAPK1KMT2A
SCHEMBL1320860 0.90 HTR2C (0.43) PRKCIHTR2CKMT2AATMKHK
SCHEMBL1322258 0.90 PRKCI (0.43) PRKCIHTR2CMAPTMAPK1KMT2A
SCHEMBL1322483 0.89 KMT2A (0.42) PRKCIHTR2CMAPTKMT2AATM
SCHEMBL1321222 0.88 HTR2C (0.43) PRKCIHTR2CMAPTKMT2AATM
SCHEMBL1322707 0.88 PRKCI (0.42) PRKCIHTR2CMAPTMAPK1KMT2A
SCHEMBL1321523 0.88 PRKCI (0.42) PRKCIHTR2CMAPTMAPK1KMT2A
Hydrochloric Acid SCHEMBL5731071 0.88 KMT2A (0.41) PRKCIHTR2CMAPTKMT2AATM
SCHEMBL1321633 0.87 ALDH1A1 (0.48) PRKCIHTR2CMAPTMAPK1KMT2A
SCHEMBL1321737 0.86 PRKCI (0.41) PRKCIHTR2CMAPTMAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1619196-A1 Substituted Pyrido[3',2':4,5]thieno[3,2-d]pyrimidines and Pyrido[3',2':4,5]furo[3,2-d]-pyrimidines for use as inhibitors of PDA-4 and/or TNF-alpha release Curacyte Discovery GmbH (DE) 2006-01-25 — — EP disclosed
Send feedback